PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare
PTC Therapeutics, Inc. Revenue 2011–2025
PTC Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- PTC Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 272.6 M, a 76.83% decrease year-over-year.
- PTC Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 1.8 B, a 132.67% increase year-over-year.
- PTC Therapeutics, Inc. annual revenue for 2025 was 1.7 B, a 114.51% increase from 2024.
- PTC Therapeutics, Inc. annual revenue for 2024 was 806.8 M, a 13.97% decrease from 2023.
- PTC Therapeutics, Inc. annual revenue for 2023 was 937.8 M, a 34.20% increase from 2022.
- PTC Therapeutics, Inc. annual revenue for 2022 was 698.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ptc Therapeutics Inc. Revenue — FAQ
Ptc Therapeutics Inc. (PTCT) revenue over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Ptc Therapeutics Inc.'s revenue?
Ptc Therapeutics Inc. (PTCT) reported revenue of $1.73B for fiscal 2025.
Where can I see PTCT's revenue history?
The chart and table above show Ptc Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.